METHOD FOR DIFFERENTIAL TREATMENT OF PATIENTS WITH HYPERTENSION AND CONCOMITANT TYPE 2 DIABETES MELLITUS

摘要

A method for differential treatment of patients with hypertensive disease and concomitant type 2 diabetes mellitus involves the determination of AGTR1 gene polymorphism. AGTR1 gene A1166C polymorphism is determined in subcompensated patients with stage 2 hypertension and moderate type 2 diabetes mellitus. If genotype (A/C + C/C) is determined, sartan (telmisartan) is prescribed, if genotype A/A is determined, angiotensin converting enzyme inhibitor (ramipril) or sartan (telmisartan) is presribed.